Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa

Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet's syndrome

(2014) A. V. Marzano et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Innate Immune Cell–Produced IL-17 Sustains Inflammation in Bullous Pemphigoid

(2014) Sébastien Le Jan et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Interleukin 17A: Toward a new understanding of psoriasis pathogenesis

(2014) Charles W. Lynde et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: A chart-verified case-control analysis

(2014) Julia Shlyankevich et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Association of Pyoderma Gangrenosum, Acne, and Suppurative Hidradenitis (PASH) Shares Genetic and Cytokine Profiles With Other Autoinflammatory Diseases

(2014) Angelo V. Marzano et al.   MEDICINE

Myeloid marker S100A8/A9 and lymphocyte marker, soluble interleukin 2 receptor: biomarkers of hidradenitis suppurativa disease activity?

(2013) C.W. Wieland et al.   BRITISH JOURNAL OF DERMATOLOGY

Autoinflammatory Skin Disorders in Inflammatory Bowel Diseases, Pyoderma Gangrenosum and Sweet’s Syndrome: a Comprehensive Review and Disease Classification Criteria

(2013) Angelo V. Marzano et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

S100A8 and S100A9 Induce Cytokine Expression and Regulate the NLRP3 Inflammasome via ROS-Dependent Activation of NF-κB1

(2013) Jean-Christophe Simard et al.   PLoS One

Hidradenitis Suppurativa

(2012) Gregor B.E. Jemec   NEW ENGLAND JOURNAL OF MEDICINE

Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β

(2011) H.H. van der Zee et al.   BRITISH JOURNAL OF DERMATOLOGY

Alterations in leucocyte subsets and histomorphology in normal-appearing perilesional skin and early and chronic hidradenitis suppurativa lesions

(2011) H.H. van der Zee et al.   BRITISH JOURNAL OF DERMATOLOGY

Pathogenesis and pharmacotherapy of Hidradenitis suppurativa

(2011) Maiwand Nazary et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

IL-17 and IL-22 enhance skin inflammation by stimulating the secretion of IL-1β by keratinocytes via the ROS-NLRP3-caspase-1 pathway

(2011) Kyung-Ah Cho et al.   INTERNATIONAL IMMUNOLOGY

Expression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativa

(2011) Christoph Schlapbach et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Hidradenitis suppurativa/acne inversa: bilocated epithelial hyperplasia with very different sequelae

(2010) M. von Laffert et al.   BRITISH JOURNAL OF DERMATOLOGY

Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases

(2010) A. V. Marzano et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Interleukin-1, inflammasomes and the skin

(2010) Laurence Feldmeyer et al.   EUROPEAN JOURNAL OF CELL BIOLOGY

Hidradenitis suppurativa (acne inversa): early inflammatory events at terminal follicles and at interfollicular epidermis*

(2009) Maximilian von Laffert et al.   EXPERIMENTAL DERMATOLOGY

The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer

(2009) Jan M. Ehrchen et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Hidradenitis suppurativa

(2009) J Revuz   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY